GanedenBC30, a branded probiotic used in multiple food and beverage categories, was approved in Australian and New Zealand for a range of digestive-health claims supported by a wealth of scientific evidence.
Photo © iStockphoto.com/rzdeb
GanedenBC30, a branded probiotic used in multiple food and beverage categories, was approved in Australian and New Zealand for a range of digestive-health claims supported by a wealth of scientific evidence.
The FSANZ (Food Standards Australia New Zealand) Food Standards code sets out the requirements for making a general-level health claim. Companies that want to make a claim can go through a systematic review of evidence of a causal food-health relationship. With 25 published papers supporting the efficacy of GanedenBC30’s benefits for digestive health, the ingredient’s manufacturers, Kerry (Beloit, WI), was able to conduct a comprehensive review in line with the ANZ Food Standards code.
The claims include “aids digestive health”, “supports digestive health”, and “boosts digestive health”. In addition to the volume of evidence supporting its benefits, as a spore-forming probiotic, GanedenBC30 remains viable through shelf life and the low pH of stomach acid, as well as processing conditions like heat, shear, and HPP pasteurization.
“As in the rest of the world, demand for probiotic products in Australia has soared in recent years,” said John Quilter, vice president and general manager for GanedenBC30, in a press release. “The door is now open for manufacturers to use messaging highlighting the many benefits of GanedenBC30. In addition to being backed by a wealth of scientific evidence, it’s a highly resilient probiotic strain, opening up opportunities for innovation in a range of food and beverage categories.”
“Consumers are increasingly skeptical and rightly asking questions about the effectiveness of functional ingredients such as probiotics,” Quilter said. “The best way to respond is by clearly communicating benefits and the research supporting them. Scientific substantiation helps manufacturers and consumers alike understand the value of ingredients and choose products that can really support health.”
Kratom sees impressive sales growth despite its regulatory status and stigma
March 12th 2025Despite its controversy, kratom is a top-selling ingredient that consumers see value in. That said, brands need to work hard to demonstrate safety and quality of kratom products in the absence of legal regulatory status. Will kratom be able to overcome its stigma for even more growth and consumer acceptance?
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”
HHS announces efforts to eliminate independent conclusion of GRAS
Published: March 11th 2025 | Updated: March 11th 2025U.S. Department of Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr., is directing the acting U.S. Food and Drug Administration’s (FDA) acting commissioner to explore rulemaking that would eliminate the independent conclusion of GRAS provision.